文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

玻璃体腔注射河豚毒素导致非人灵长类视网膜失活的剂量-反应特征

Dose-Response Characteristics of Retinal Inactivation Due to Intravitreal Injections of Tetrodotoxin in Nonhuman Primates.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究在3只成年和4只婴儿非人灵长类中玻璃体腔注射不同剂量河豚毒素(TTX,115-4800 ng),发现视网膜失活持续时间呈剂量依赖性,低剂量(115-230 ng)失活长达4天,中剂量(460-920 ng)延长至8天,高剂量(4800 ng)使视觉诱发电位消失长达10天;失活后OCT、ERG和组织学检查未见视网膜结构或功能明显改变。

要点

  • TTX所致视网膜失活持续时间与剂量相关,可实现可控可逆的失活。
  • 失活后视网膜结构和功能未见永久性损害,安全性指标良好。
  • 该剂量-反应关系为后续在弱视猴中测试疗效奠定基础。

核心结论

  • 玻璃体腔注射TTX在所检剂量下不导致灵长类永久性视觉损害,且失活持续时间可通过剂量滴定。

研究设计与样本

  • 研究纳入3只成年和4只婴儿非人灵长类,接受不同剂量TTX(115-4800 ng)玻璃体腔注射。
  • 成年动物通过对比敏感度函数(CSF)评估失活持续时间,婴儿动物通过视觉诱发电位(VEP)评估。
  • 安全性通过光学相干断层扫描(OCT)、视网膜电图(ERG)、视网膜组织学和相对传入性瞳孔缺陷(RAPD)临床评估。

主要发现

  • 失活持续时间呈剂量依赖性:低剂量(115-230 ng)失活长达4天。
  • 中剂量(460-920 ng)失活延长至8天。
  • 最高剂量(4800 ng)使VEP反应消失长达10天。
  • 注射后早期出现的RAPD在CSF和VEP恢复至基线时约同时消失。
  • 失活后OCT、ERG或组织学评估未显示视网膜结构或功能的可辨别改变。

关键数值与推荐

  • 低剂量(115-230 ng)视网膜失活持续长达4天。
  • 中剂量(460-920 ng)失活持续长达8天。
  • 高剂量(4800 ng)VEP反应消失长达10天。

临床怎么用

  • TTX玻璃体腔注射可实现剂量依赖、可逆的视网膜失活,且在所检剂量下未观察到永久性视网膜结构或功能损害。
  • 该剂量-反应关系可为未来在弱视猴中测试该治疗策略的疗效提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Temporary retinal inactivation of the fellow eye with intravitreal tetrodotoxin (TTX) has shown promise as a treatment strategy for deprivation amblyopia in mouse and cat models. The purpose of this study was to evaluate the duration of retinal inactivation achieved with different doses of TTX in nonhuman primates (NHPs), while also assessing functional and structural measures of vision to determine the safety of this treatment approach. METHODS: Three adult and four infant NHPs received varying doses of TTX (115-4800 ng) via intravitreal injection. Inactivation duration was assessed via contrast sensitivity function (CSF) in awake-behaving adults and visual evoked potential (VEP) responses in anesthetized infants. Safety of the TTX approach was investigated using optical coherence tomography (OCT), electroretinogram (ERG), retinal histology, and clinical evaluation of a relative afferent pupillary defect (RAPD). RESULTS: Inactivation duration was dose dependent. Low doses (115-230 ng) resulted in up to 4 days of inactivation. Intermediate doses (460-920 ng) extended inactivation up to 8 days, whereas the highest dose (4800 ng) eliminated VEP responses for up to 10 days. RAPD that emerged soon after the injection was absent at about the same time as CSF and VEP responses recovered to baseline. Post-inactivation assessments using OCT, ERG, or histology showed no discernible changes in retinal structure or function. CONCLUSIONS: Intravitreal TTX at the doses examined does not cause permanent disruption of vision in primates, and the duration of retinal inactivation can be titrated by dose. The dose-response relationship provides a foundation for future studies testing the efficacy of this treatment approach in amblyopic monkeys.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kwaw RJ, Duffy KR, Meng H, et al. Dose-Response Characteristics of Retinal Inactivation Due to Intravitreal Injections of Tetrodotoxin in Nonhuman Primates. Invest Ophthalmol Vis Sci. 2026. PMID: 42257410. doi:10.1167/iovs.67.6.12

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。